Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy IGM Biosciences stock

Learn how to easily invest in IGM Biosciences stock.

IGM Biosciences Inc is a biotechnology business based in the US. IGM Biosciences shares (IGMS) are listed on the NASDAQ and all prices are listed in US Dollars. IGM Biosciences employs 217 staff and has a trailing 12-month revenue of around $366,000.

How to buy shares in IGM Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IGMS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

IGM Biosciences stock price (NASDAQ: IGMS)

Use our graph to track the performance of IGMS stocks over time.

IGM Biosciences shares at a glance

Information last updated 2022-09-26.
Latest market close$19.43
52-week range$12.67 - $74.60
50-day moving average $20.23
200-day moving average $20.03
Wall St. target price$42.80
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-5.52

Buy IGM Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy IGM Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IGM Biosciences price performance over time

Historical closes compared with the close of $19.43 from 2022-09-29

1 week (2022-09-23) 1.20%
1 month (2022-09-01) -2.26%
3 months (2022-07-01) 5.77%
6 months (2022-03-28) N/A
1 year (2021-10-01) -70.52%
2 years (2020-10-01) -74.48%
3 years (2019-10-01) 9.90%
5 years (2017-09-27) N/A

IGM Biosciences financials

Revenue TTM $366,000
Gross profit TTM $-39,161,000
Return on assets TTM -27.61%
Return on equity TTM -58.84%
Profit margin 0%
Book value $8.80
Market capitalisation $819 million

TTM: trailing 12 months

IGM Biosciences share dividends

We're not expecting IGM Biosciences to pay a dividend over the next 12 months.

IGM Biosciences share price volatility

Over the last 12 months, IGM Biosciences's shares have ranged in value from as little as $12.67 up to $74.6. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IGM Biosciences's is -0.3368. This would suggest that IGM Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, IGM Biosciences has bucked the trend.

IGM Biosciences overview

IGM Biosciences, Inc. , a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc.

Frequently asked questions

What percentage of IGM Biosciences is owned by insiders or institutions?
Currently 38.753% of IGM Biosciences shares are held by insiders and 62.885% by institutions.
How many people work for IGM Biosciences?
Latest data suggests 217 work at IGM Biosciences.
When does the fiscal year end for IGM Biosciences?
IGM Biosciences's fiscal year ends in December.
Where is IGM Biosciences based?
IGM Biosciences's address is: 325 East Middlefield Road, Mountain View, CA, United States, 94043
What is IGM Biosciences's ISIN number?
IGM Biosciences's international securities identification number is: US4495851085
What is IGM Biosciences's CUSIP number?
IGM Biosciences's Committee on Uniform Securities Identification Procedures number is: 449585108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site